Arai T, Hayashi E, Maeda S, Matsubara T, Fujii H, Shinohara K, Sogabe A, Wainai S, Tanaka D, Ono Y, Ono Y, Yoshikai M, Sorimachi Y, Kok CY, Shimoda M, Tanaka M, Kawada N, Goda N.
Nat Commun. 2025 Mar 13;16(1):1950. doi: 10.1038/s41467-025-57167-0.
Interruption of glucagon signaling augments islet non-alpha cell proliferation in SLC7A2- and mTOR-dependent manners.
Coate KC, Dai C, Singh A, Stanley J, Covington BA, Bradley A, Oladipupo F, Gong Y, Wisniewski S, Sellick K, Spears E, Poffenberger G, Schornack AMR, Bustabad A, Rodgers T, Dey N, Shultz LD, Greiner DL, Yan H, Powers AC, Chen W, Dean ED.
Mol Metab. 2024 Dec;90:102050. doi: 10.1016/j.molmet.2024.102050. Epub 2024 Oct 20.
PMID:39433176
Pathologic pancreatic endocrine cell hyperplasia.
Ouyang D, Dhall D, Yu R.
World J Gastroenterol. 2011 Jan 14;17(2):137-43. doi: 10.3748/wjg.v17.i2.137.
PMID:21245985
beta-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity.
Mezza T, Cinti F, Cefalo CMA, Pontecorvi A, Kulkarni RN, Giaccari A.
Unno M, Itoh T, Watanabe T, Miyashita H, Moriizumi S, Teraoka H, Yonekura H, Okamoto H.
Adv Exp Med Biol. 1992;321:61-6; discussion 67-9. doi: 10.1007/978-1-4615-3448-8_8.
PMID:1449083
gamma-aminobutyric acid modulates alpha-cell hyperplasia but not beta-cell regeneration induced by glucagon receptor antagonism in type 1 diabetic mice.
Gu L, Cui X, Lin X, Yang J, Wei R, Hong T, Yang K.
Dysregulated insulin secretion is associated with pancreatic beta-cell hyperplasia and direct acinar-beta-cell trans-differentiation in partially eNOS-deficient mice.
Novelli M, Masini M, Vecoli C, Moscato S, Funel N, Pippa A, Mattii L, Ippolito C, Campani D, Neglia D, Masiello P.